Latest Commercialisation News

Australian Rare Earths (ASX: AR3) has successfully commissioned and begun pilot-scale processing of 30 tonnes of ore at ANSTO’s Sydney facility, producing high-purity rare earth oxide samples to support commercialisation and a bankable feasibility study.

Sparc Hydrogen has partnered with US-based SunHydrogen to integrate and test solar-driven green hydrogen modules, hitting a notable 10% solar-to-hydrogen efficiency in early trials. This collaboration aims to advance pilot-scale testing and techno-economic analysis to lower hydrogen production costs.

Blue Star Helium has delivered its third helium trailer from the Pinon Canyon Plant, signalling steady progress toward full production capacity. A fourth trailer is currently being filled as the company pursues further plant optimisation and commercialisation of CO2 byproduct.

Lithium Universe Limited (ASX: LU7) has reported laboratory success for its licensed GCDE technology, achieving over 99% gold recovery and 97% purity from chloride solutions and e-waste, positioning it as a greener alternative in precious metals extraction.

LTR Pharma reports a 93% response rate in men seeking convenience and spontaneity with SPONTAN, alongside a 64% response in post-prostatectomy patients, highlighting potential for its rapid-onset intranasal ED treatment in challenging populations.

Bio-Gene Technology has raised approximately A$3.275 million through its second tranche placement and share purchase plan underwriting, issuing over 51 million new shares and 69 million options to investors.

ReNerve Limited has gained marketing approval for its flagship NervAlign Nerve Cuff in India, marking a critical milestone in its global expansion and enabling commercial rollout in one of the world's largest nerve repair markets.

Metallium Limited has appointed key board members and executives to strengthen governance and operational capacity as it advances its Flash Joule Heating technology towards commercialisation in the US.

Flynn Gold is kicking off a 2,500m drilling campaign at its Brilliant Prospect in northeast Tasmania, aiming to convert promising trench assay results into a formal Mineral Resource and fast-track project development.

Wide Open Agriculture (ASX: WOA) has taken a significant step towards a capital-light production model by signing a non-binding framework agreement with Proeon Foods for contract manufacturing of its lupin-based ingredients, including exclusive Indian distribution rights.

BPM Minerals has kicked off a record 20,000m reverse circulation drilling campaign at its Forelands Gold Project in Western Australia, targeting a maiden JORC-compliant resource at Beachcomber and preparing for maiden drilling at Bonnie & Clyde.

EVE Health Group has progressed its Libbo pilot clinical study for erectile dysfunction with dosing set for Q4 2026 and achieved a major solubility breakthrough for apixaban, while appointing Ben Rohr as CEO to drive commercial growth.